Treatment Registry
Compare
Menu

Company

Found

Found publishes compounded semaglutide and compounded tirzepatide at $289 a month — Monthly plan, cash pay.

Published by Treatment Registry · Latest research

  • 4 programs
  • 2 identified molecules
  • 8 readings

Read from joinfound.com; latest program check September 2026. Individual programs and sources may have earlier verification dates.

Go to Found

Enroll with Found

This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.

What it costs

first month, including required fees on record · Monthly plan, cash pay

first month, including required fees on record · Monthly plan, cash pay

Terms

Pharmacy

Not disclosed

Across recorded programs · Evidence: August 2026

Consultation fee

Charged; amount not published. Found's brand-medication prices carry a footnote reading "Cost does not include the subscription fees and clinical care, which vary depending on coverage." It applies to the brand path; the compounded program prices in the ladder above include access to Found's clinicians. Found publishes no figure for that excluded subscription fee, and its own FAQ puts insured members' visit copays at "typically around $30" without fixing them, so nothing is added here.

Across recorded programs · Evidence: September 2026

States

Not disclosed

Across recorded programs · Evidence: September 2026

Not yet checked: membership.

Programs

EntryProgramRecorded price
with its payment basis		Link
EntryTR-0105ProgramCompounded semaglutideRecorded price$289
Per month · Monthly plan, cash pay		EnrollPaid link
EntryTR-0106ProgramCompounded tirzepatideRecorded price$289
Per month · Monthly plan, cash pay		EnrollPaid link
EntryTR-0107Not verifiedProgramBrand semaglutideRecorded price$1,100

Historical recorded price · September 2026 · not currently verified


Per month · brand semaglutide - Ozempic (12-month plan, per medication toolkit listing)		Record
EntryTR-0108Not verifiedProgramBrand tirzepatideRecorded price$650

Historical recorded price · September 2026 · not currently verified


Per month · brand tirzepatide - Zepbound		Record

Notes

Pricing details, service terms and questions to confirm before enrolling.

September 2026

  1. 1. Found publishes a 41-state list, but it is headed "Insurance plans accepted in" — that is where its insurance billing works, not where it will treat you. The site does not separately say which states the program itself covers, so no coverage is recorded here.

August 2026

  1. 2. Found's headline price depends on insurance, and its footnote quietly doubles the cash-pay figure for anyone paying monthly. The ladder on its pricing page reads: "Found's GLP-1 Program starting at $99/mo with insurance* $169/mo with cash pay* — Access to board-certified Found clinicians* — Personalized care plan with GLP-1s", footnoted: "*Pricing based on 12-month plans paid up-front. Monthly plans start at $199/mo for insurance and $289/mo for cash-pay. Visits for insurance plans may require copays. Prescriptions are up to medical provider's discretion. Price varies based on medication, insurance and coverage."
Show 6 more notesHide 6 more notes
  1. 3. Found's home page FAQ states the same $99 starting price without any of the conditions attached elsewhere on the site. It reads: "On medication, Found offers more options than any other program: compounded GLP-1s starting at $99/month (with flat pricing as your dose increases), branded GLP-1s like Wegovy and Zepbound with insurance navigation support or direct-pay options, and non-GLP-1 plan options starting at $49/month. Longer plans at 3, 6, and 12 months keep your monthly cost down." Neither the insurance requirement nor the twelve-month prepay shows up in that answer.
  2. 4. Found's home page advertises a discount for switching to a prepaid annual plan: "Get up to $100 off your membership plan today!‡", with the terms spelling out the mechanics: "‡Offer Details: Save $100/mo or more on compounded tirzepatide and semaglutide when you choose a prepaid annual plan, compared to paying monthly. Save $100 off today's checkout supporting brand-name GLP-1 prescriptions (including Zepbound® vials, Wegovy® pens, and Wegovy® pills) when paying cash for your Found Membership. Save $50 off today's checkout on plans supporting brand-name GLP-1 prescriptions when Found is in-network with your insurance. Med Kit plans are excluded from all discounts. This offer is valid for a one-time redemption per account." The math checks out: on Found's own published figures, the annual-versus-monthly gap for a cash payer is $289 minus $169, or $120 a month, which does satisfy "$100/mo or more".
  3. 5. Found prices brand-name drugs but leaves its own compounded options blank. Its medication toolkit, on the home page and the pricing page alike, lists "Ozempic® $1100/mo", "Wegovy® from $650/mo+", "Zepbound® from $650/mo+", "Mounjaro® ~$1100/mo", "Saxenda® Pricing varies", "Victoza® Pricing varies", and "Foundayo™" with no figure. The compounded tirzepatide and compounded semaglutide cards in the same grid carry no figure either. All are footnoted "**Cost does not include the subscription fees and clinical care, which vary depending on coverage."
  4. 6. On insurance and copays, from the pricing page FAQ: "Cash-pay plans: You'll pay the price listed for your selected plan – no hidden fees. With Insurance: You'll pay your plan cost plus your copay, which is typically around $30 for most Found members. Your exact copay may vary based on your insurance plan and deductible status." And from the home page: "Covered by insurance for 1 in 3 Americans with copays under $30/visit for most. Medication cost separate."
  5. 7. Found advertises a flat $50-a-month Medicare price, then qualifies it heavily. The home page reads: "Get Wegovy®, Foundayo®, or Zepbound® for as little as $50/mo through Medicare. The Medicare GLP-1 Bridge Program helps eligible Part D members access brand-name GLP-1 medications for as little as $50/month." And beneath it: "For eligible Medicare Part D members with a qualifying GLP-1 prescription for weight management. This is not a guarantee of coverage. Actual eligibility is determined by the Medicare GLP-1 Bridge program's criteria. The $50 copay does not count toward your Part D deductible or out-of-pocket maximum, and low-income subsidies (LIS/Extra Help) do not apply. Found is not affiliated with or endorsed by CMS."
  6. 8. The annual totals above are our multiplication of Found's own per-month figures, because Found publishes none: $169 × 12 = $2,028 for the cash annual plan and $99 × 12 = $1,188 for the insurance one.

Understand the terms

Before you act

Compare Found with

Cite this

Treatment Registry. (2026). Found: recorded programs and prices. Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/found